Temporal Profile of Microtubule-Associated Protein 2: A Novel Indicator of Diffuse Brain Injury Severity and Early Mortality after Brain Trauma.
暂无分享,去创建一个
Shelley Heaton | A. Gabrielli | C. Robertson | H. Hannay | R. Hayes | G. Brophy | Kevin K. W. Wang | L. Papa | I. Schmalfuss | Linda Papa | Claudia S Robertson | Gretchen M Brophy | Ronald L Hayes | Kevin K W Wang | S. Robicsek | Ilona Schmalfuss | H Julia Hannay | Andrea Gabrielli | Steven A Robicsek | Gretchen M. Brophy | S. Heaton | Claudia S. Robertson | Kevin K W Wang | Ronald L. Hayes | H. Hannay | Steven A. Robicsek
[1] A. Gabrielli,et al. alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury. , 2009, Journal of neurotrauma.
[2] B. Jennett,et al. Assessment and prognosis of coma after head injury , 2005, Acta Neurochirurgica.
[3] K. Mikoshiba,et al. Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage—Immunohistochemical investigation of dendritic damage , 1989, Neuroscience.
[4] A. Gabrielli,et al. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury* , 2010, Critical care medicine.
[5] G. Brophy,et al. Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury. , 2016, JAMA neurology.
[6] W. Paiva,et al. Diffuse Axonal Injury: Epidemiology, Outcome and Associated Risk Factors , 2016, Front. Neurol..
[7] B. Jennett,et al. Assessment of coma and impaired consciousness. A practical scale. , 1974, Lancet.
[8] R. Hayes,et al. Microtubule-associated protein 2 levels decrease in hippocampus following traumatic brain injury. , 1992, Journal of neurotrauma.
[9] Robert Siman,et al. Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo , 1988, Neuron.
[10] J. Geddes,et al. Microtubular Proteolysis in Focal Cerebral Ischemia , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] L. Papa. Exploring the Role of Biomarkers for the Diagnosis and Management of Traumatic Brain Injury Patients , 2012 .
[12] R. Hayes,et al. Diminished microtubule-associated protein 2 (MAP2) immunoreactivity following cortical impact brain injury. , 1996, Journal of neurotrauma.
[13] C. Robertson,et al. Clinical Significance of αII-Spectrin Breakdown Products in Cerebrospinal Fluid after Severe Traumatic Brain Injury , 2007 .
[14] Ewout W. Steyerberg,et al. Predicting 14-day mortality after severe traumatic brain injury: application of the IMPACT models in the brain trauma foundation TBI-trac® New York State database. , 2012, Journal of neurotrauma.
[15] Juan Lu,et al. Predicting Outcome after Traumatic Brain Injury: Development and International Validation of Prognostic Scores Based on Admission Characteristics , 2008, PLoS medicine.
[16] A. Gabrielli,et al. Use of biomarkers for diagnosis and management of traumatic brain injury patients. , 2008, Expert opinion on medical diagnostics.
[17] I. Kureshi,et al. Comparison of percutaneous ventriculostomies and intraparenchymal monitor: a retrospective evaluation of 156 patients. , 1998, Acta neurochirurgica. Supplement.
[18] M A Foulkes,et al. The diagnosis of head injury requires a classification based on computed axial tomography. , 1992, Journal of neurotrauma.
[19] J. Rafols,et al. Disruption of MAP-2 immunostaining in rat hippocampus after traumatic brain injury. , 1998, Journal of neurotrauma.
[20] A. Gabrielli,et al. Biomarkers Improve Clinical Outcome Predictors of Mortality Following Non-Penetrating Severe Traumatic Brain Injury , 2015, Neurocritical Care.
[21] D. Graham,et al. The neuronal cytoskeleton is at risk after mild and moderate brain injury. , 1998, Journal of neurotrauma.